Unlisted Shares
Maverick Simulation Solutions Limited
Maverick Simulation Solutions Limited (Unlisted)
Verified Unlisted CompanyOff-market Transfer · NSDL / CDSL
About Maverick Simulation Solutions Limited
Maverick Simulation Solutions Limited is a Delhi-based medtech company that creates simulation tools for medical and nursing training. It provides realistic simulation mannequins and virtual reality solutions to train surgeons, doctors, and nurses. The company replaces traditional classroom learning with hands-on, risk-free practice using real patient scenarios.
Share Details
| company Name | Maverick Simulation Solutions Limited (Unlisted) |
| indicative Unlisted Share Price | ₹2750 |
| market Capitalization | ₹980 Crore |
| lot Size | 100 |
| 52 Week High | ₹2800 |
| 52 Week Low | ₹1995 |
| face Value | ₹10 |
| book Value | 217.57 |
| pe Ratio | 20.51 |
| pb Ratio | 9.17 |
| debt To Equity | 0.24 |
| return On Equity | 49.32 |
| total Outstanding Shares | 491381 |
| isin | U26990DL2012PLC239501 |
| depository | NSDL & CDSL |
| pan | AAICM2519C |
| cin | U26990DL2012PLC239501 |
| rta | MUFG Intime India |
Income Statement (Profit & Loss) (₹ in Crore)
| Particulars | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | - | - | 14.2 | 136.3 |
| EBITDA | - | - | 1.12 | 61.34 |
| PBT | - | - | 1.26 | 61.3 |
| Net Profit / Loss (PAT) | - | - | 0.94 | 47.8 |
| EPS | - | - | 1.98 | 97.35 |
Key Financial Ratios (Last 3–5 Years)
| Ratio | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Operating Profit Margin (%) | - | - | 7.89 | 45 |
| Net Profit Margin (%) | - | - | 6.62 | 35.07 |
| Earning Per Share (Diluted) | - | - | 1.98 | 97.35 |
Financial Annual Report Summary
Maverick Simulation has shown explosive revenue growth in FY25 (from ₹14.2 Cr to ₹136.3 Cr) with massive improvement in profitability. Strong scalability in medtech simulation products.
Why Invest in Maverick Simulation Solutions
- Explosive revenue growth in FY25.
- High ROE of 49.32% and healthy margins.
- Strong medtech innovation with scalable business model.
Balance Sheet - Assets (₹ in Crore)
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Fixed Assets | - | - | 0.47 | 5.5 |
| CWIP | - | - | 0 | 0 |
| Investments | - | - | 0 | 0 |
| Trade Receivables | - | - | 5 | 105.4 |
| Inventory | - | - | 38 | 14.4 |
| Other Assets | - | - | 43.53 | 37.7 |
| Total Assets | - | - | 87 | 163 |
Balance Sheet - Liabilities & Equity (₹ in Crore)
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Share Capital | - | - | 4.75 | 4.91 |
| FV | - | - | 10 | 10 |
| Reserves | - | - | 21 | 92 |
| Borrowings | - | - | 7.8 | 23 |
| Trade Payables | - | - | 27 | 17.7 |
| Other Liabilities | - | - | 26.45 | 25.39 |
| Total Liabilities | - | - | 87 | 163 |
Liabilities Breakdown & Balance Sheet Insights
Balance Sheet Insights
Debt to Equity ratio of 0.24. Significant increase in receivables due to revenue growth.
Liabilities Breakdown
Debt to Equity ratio of 0.24.
Additional Insights
Strong equity growth with moderate debt. High growth in trade receivables reflecting business expansion.
Cash Flow Insights
- Negative operating cash flow due to working capital increase (high receivables).
- Funded through equity and borrowings.
Shareholding Pattern
Recent
Promoter: High (Founders)
Institutional: Not Available
Public: Not Available
Promoters & Management
Led by Anuj Chahal (Founder & CEO with 20+ years experience).
Key Management
Anuj Chahal - Founder & CEO
20+ Years
Dr. Sunil Tomar - Director
20+ Years
Registrar & Transfer Agent (RTA)
Registrar: MUFG Intime India
Website: https://in.mu-fg.com/
Management Analysis
Focus on innovation in medical simulation technology to revolutionize healthcare training with realistic, risk-free practice solutions.
Frequently Asked Questions About Maverick Simulation Solutions Limited
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.